Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03263702 · ClinicalTrials.gov registry record · NA
RADAR Clinical Trial
A NA study of Persistent Atrial Fibrillation, sponsored by Vivek Reddy.
- Completed
- Registry status
- NA
- Development phase
- 65
- Enrollment target
- 4
- Study locations
NCT03263702 is a NA study of Persistent Atrial Fibrillation that has completed, run by Vivek Reddy. The registered enrollment target is 65 participants, below the 1,256-participant average among 15 other Persistent Atrial Fibrillation trials with a reported enrollment target (95% lower). The trial reports 4 study locations across 3 states.
The verdict
NCT03263702, a NA study of Persistent Atrial Fibrillation, has completed, sponsored by Vivek Reddy.
- COMPLETED
- Registry status
- NA
- Development phase
- 65 participants
- Enrollment target
- 4
- Study locations
Study Summary
This prospective, multicenter, observational study will examine the ability of real time electrogram processing mapping to identify driver domains to target for ablation in persistent AF patients.
Conditions Studied
Interventions
- DEVICE Computational Mapping Algorithm
Study Locations (4)
Colorado
- University of Colorado Medical Center - Denver
- South Denver Cardiology - Denver
Massachusetts
- Massachusetts General Hospital - Boston
New York
- Icahn School of Medicine at Mount Sinai - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2017-06-26 |
| Est. Completion | 2019-06-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03263702
The ClinicalTrials.gov registry entry for NCT03263702 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 65 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,256-participant average among 15 other Persistent Atrial Fibrillation trials with a reported enrollment target (95% lower). The listed sponsor is Vivek Reddy, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Persistent Atrial Fibrillation appearing as the primary indexed condition, and to 1 intervention - of which Computational Mapping Algorithm is the first listed.
NCT03263702 reports 4 study locations spanning 3 distinct geographic areas - top geographies include Colorado, Massachusetts, New York.
Frequently Asked Questions
What is clinical trial NCT03263702 about?
NCT03263702 is a clinical study titled "RADAR Clinical Trial". This prospective, multicenter, observational study will examine the ability of real time electrogram processing mapping to identify driver domains to target for ablation in persistent AF patients.
What is the current status of trial NCT03263702?
This trial is currently completed. It is a NA study. The enrollment target is 65 participants. The study started on 2017-06-26. Estimated completion is 2019-06-07.
What conditions does trial NCT03263702 study?
This clinical trial studies the following conditions: Persistent Atrial Fibrillation.
What interventions are being tested in trial NCT03263702?
The interventions under investigation include: Computational Mapping Algorithm (DEVICE).
Who is sponsoring clinical trial NCT03263702?
This trial is sponsored by Vivek Reddy, which has 20 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03263702 being conducted?
This trial has 4 study locations across Colorado, Massachusetts, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Persistent Atrial Fibrillation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Endocardial Mapping With the CoreMap EP Mapping System
RECRUITING · NA
-
ULTRA-HFIB-Redo: Ultrasound-based Renal Sympathetic Denervation vs Control in Redo Ablation Patients
RECRUITING · NA
-
ARIADNE Clinical Trial
RECRUITING · NA
-
Medtronic Terminate AF Study
RECRUITING · NA
-
Repeat Ablation of Persistent Atrial Fibrillation, Including Mitral Isthmus Catheter Ablation, With the FARAPULSE Pulsed Field Ablation System
RECRUITING · NA
-
Pulsed Field Ablation (PFA) vs Anti-Arrhythmic Drug (AAD) Therapy as a First Line Treatment for Persistent Atrial Fibrillation
ACTIVE NOT RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.